nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCB11—Dexamethasone—ankylosing spondylitis	0.366	0.431	CbGbCtD
Fluorescein—ABCC1—Methotrexate—ankylosing spondylitis	0.209	0.246	CbGbCtD
Fluorescein—CYP1A1—Dexamethasone—ankylosing spondylitis	0.161	0.189	CbGbCtD
Fluorescein—SLC22A6—Methotrexate—ankylosing spondylitis	0.113	0.133	CbGbCtD
Fluorescein—Pulmonary oedema—Dexamethasone—ankylosing spondylitis	0.00127	0.00838	CcSEcCtD
Fluorescein—Pulmonary oedema—Betamethasone—ankylosing spondylitis	0.00127	0.00838	CcSEcCtD
Fluorescein—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.0012	0.00789	CcSEcCtD
Fluorescein—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.0012	0.00789	CcSEcCtD
Fluorescein—Extravasation—Methotrexate—ankylosing spondylitis	0.00119	0.00785	CcSEcCtD
Fluorescein—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00118	0.00779	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.00118	0.00778	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.00118	0.00776	CcSEcCtD
Fluorescein—Skin discolouration—Methotrexate—ankylosing spondylitis	0.00115	0.00759	CcSEcCtD
Fluorescein—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.00111	0.0073	CcSEcCtD
Fluorescein—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00108	0.00716	CcSEcCtD
Fluorescein—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00108	0.00715	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.00107	0.00706	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.00107	0.00706	CcSEcCtD
Fluorescein—Respiratory failure—Methotrexate—ankylosing spondylitis	0.00106	0.00698	CcSEcCtD
Fluorescein—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.00104	0.00687	CcSEcCtD
Fluorescein—Asthma—Triamcinolone—ankylosing spondylitis	0.000986	0.00651	CcSEcCtD
Fluorescein—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000984	0.0065	CcSEcCtD
Fluorescein—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000984	0.0065	CcSEcCtD
Fluorescein—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.000968	0.00639	CcSEcCtD
Fluorescein—Neoplasm—Methotrexate—ankylosing spondylitis	0.000938	0.00619	CcSEcCtD
Fluorescein—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.000924	0.0061	CcSEcCtD
Fluorescein—Bradycardia—Prednisolone—ankylosing spondylitis	0.000874	0.00577	CcSEcCtD
Fluorescein—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00087	0.00575	CcSEcCtD
Fluorescein—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000857	0.00566	CcSEcCtD
Fluorescein—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000804	0.0053	CcSEcCtD
Fluorescein—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000802	0.00529	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000779	0.00514	CcSEcCtD
Fluorescein—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.000769	0.00508	CcSEcCtD
Fluorescein—Erythema—Prednisolone—ankylosing spondylitis	0.000747	0.00493	CcSEcCtD
Fluorescein—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000731	0.00482	CcSEcCtD
Fluorescein—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000729	0.00481	CcSEcCtD
Fluorescein—Bradycardia—Betamethasone—ankylosing spondylitis	0.000729	0.00481	CcSEcCtD
Fluorescein—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000715	0.00472	CcSEcCtD
Fluorescein—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000711	0.0047	CcSEcCtD
Fluorescein—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00071	0.00469	CcSEcCtD
Fluorescein—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000693	0.00458	CcSEcCtD
Fluorescein—Erythema—Triamcinolone—ankylosing spondylitis	0.000687	0.00454	CcSEcCtD
Fluorescein—Erythema—Methylprednisolone—ankylosing spondylitis	0.000686	0.00453	CcSEcCtD
Fluorescein—Malaise—Prednisolone—ankylosing spondylitis	0.000674	0.00445	CcSEcCtD
Fluorescein—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000673	0.00444	CcSEcCtD
Fluorescein—Syncope—Prednisolone—ankylosing spondylitis	0.00067	0.00442	CcSEcCtD
Fluorescein—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000657	0.00433	CcSEcCtD
Fluorescein—Asthma—Methotrexate—ankylosing spondylitis	0.000651	0.0043	CcSEcCtD
Fluorescein—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00065	0.00429	CcSEcCtD
Fluorescein—Angiopathy—Betamethasone—ankylosing spondylitis	0.00065	0.00429	CcSEcCtD
Fluorescein—Convulsion—Prednisolone—ankylosing spondylitis	0.000647	0.00427	CcSEcCtD
Fluorescein—Hypertension—Prednisolone—ankylosing spondylitis	0.000645	0.00426	CcSEcCtD
Fluorescein—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000638	0.00421	CcSEcCtD
Fluorescein—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000636	0.0042	CcSEcCtD
Fluorescein—Bradycardia—Prednisone—ankylosing spondylitis	0.000635	0.00419	CcSEcCtD
Fluorescein—Discomfort—Prednisolone—ankylosing spondylitis	0.000629	0.00415	CcSEcCtD
Fluorescein—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000624	0.00412	CcSEcCtD
Fluorescein—Erythema—Dexamethasone—ankylosing spondylitis	0.000623	0.00412	CcSEcCtD
Fluorescein—Erythema—Betamethasone—ankylosing spondylitis	0.000623	0.00412	CcSEcCtD
Fluorescein—Malaise—Triamcinolone—ankylosing spondylitis	0.00062	0.00409	CcSEcCtD
Fluorescein—Malaise—Methylprednisolone—ankylosing spondylitis	0.000618	0.00408	CcSEcCtD
Fluorescein—Syncope—Triamcinolone—ankylosing spondylitis	0.000616	0.00407	CcSEcCtD
Fluorescein—Syncope—Methylprednisolone—ankylosing spondylitis	0.000615	0.00406	CcSEcCtD
Fluorescein—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00061	0.00403	CcSEcCtD
Fluorescein—Oedema—Prednisolone—ankylosing spondylitis	0.00061	0.00403	CcSEcCtD
Fluorescein—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000604	0.00399	CcSEcCtD
Fluorescein—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000603	0.00398	CcSEcCtD
Fluorescein—Shock—Prednisolone—ankylosing spondylitis	0.0006	0.00396	CcSEcCtD
Fluorescein—Cough—Triamcinolone—ankylosing spondylitis	0.0006	0.00396	CcSEcCtD
Fluorescein—Convulsion—Triamcinolone—ankylosing spondylitis	0.000595	0.00393	CcSEcCtD
Fluorescein—Tachycardia—Prednisolone—ankylosing spondylitis	0.000595	0.00393	CcSEcCtD
Fluorescein—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000594	0.00392	CcSEcCtD
Fluorescein—Hypertension—Triamcinolone—ankylosing spondylitis	0.000593	0.00392	CcSEcCtD
Fluorescein—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000592	0.00391	CcSEcCtD
Fluorescein—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00059	0.00389	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00058	0.00383	CcSEcCtD
Fluorescein—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000578	0.00382	CcSEcCtD
Fluorescein—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000578	0.00382	CcSEcCtD
Fluorescein—Discomfort—Triamcinolone—ankylosing spondylitis	0.000578	0.00382	CcSEcCtD
Fluorescein—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000577	0.00381	CcSEcCtD
Fluorescein—Angiopathy—Prednisone—ankylosing spondylitis	0.000566	0.00374	CcSEcCtD
Fluorescein—Immune system disorder—Prednisone—ankylosing spondylitis	0.000563	0.00372	CcSEcCtD
Fluorescein—Malaise—Betamethasone—ankylosing spondylitis	0.000562	0.00371	CcSEcCtD
Fluorescein—Malaise—Dexamethasone—ankylosing spondylitis	0.000562	0.00371	CcSEcCtD
Fluorescein—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000561	0.0037	CcSEcCtD
Fluorescein—Oedema—Triamcinolone—ankylosing spondylitis	0.000561	0.0037	CcSEcCtD
Fluorescein—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00056	0.00369	CcSEcCtD
Fluorescein—Syncope—Betamethasone—ankylosing spondylitis	0.000559	0.00369	CcSEcCtD
Fluorescein—Syncope—Dexamethasone—ankylosing spondylitis	0.000559	0.00369	CcSEcCtD
Fluorescein—Shock—Triamcinolone—ankylosing spondylitis	0.000552	0.00364	CcSEcCtD
Fluorescein—Shock—Methylprednisolone—ankylosing spondylitis	0.000551	0.00363	CcSEcCtD
Fluorescein—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000549	0.00362	CcSEcCtD
Fluorescein—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000548	0.00362	CcSEcCtD
Fluorescein—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000548	0.00362	CcSEcCtD
Fluorescein—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000548	0.00361	CcSEcCtD
Fluorescein—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000547	0.00361	CcSEcCtD
Fluorescein—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000546	0.0036	CcSEcCtD
Fluorescein—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000543	0.00359	CcSEcCtD
Fluorescein—Erythema—Prednisone—ankylosing spondylitis	0.000543	0.00358	CcSEcCtD
Fluorescein—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000542	0.00358	CcSEcCtD
Fluorescein—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000541	0.00357	CcSEcCtD
Fluorescein—Convulsion—Betamethasone—ankylosing spondylitis	0.00054	0.00357	CcSEcCtD
Fluorescein—Convulsion—Dexamethasone—ankylosing spondylitis	0.00054	0.00357	CcSEcCtD
Fluorescein—Hypertension—Betamethasone—ankylosing spondylitis	0.000538	0.00355	CcSEcCtD
Fluorescein—Hypertension—Dexamethasone—ankylosing spondylitis	0.000538	0.00355	CcSEcCtD
Fluorescein—Discomfort—Dexamethasone—ankylosing spondylitis	0.000524	0.00346	CcSEcCtD
Fluorescein—Discomfort—Betamethasone—ankylosing spondylitis	0.000524	0.00346	CcSEcCtD
Fluorescein—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000523	0.00345	CcSEcCtD
Fluorescein—Pain—Prednisolone—ankylosing spondylitis	0.000521	0.00344	CcSEcCtD
Fluorescein—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000509	0.00336	CcSEcCtD
Fluorescein—Oedema—Dexamethasone—ankylosing spondylitis	0.000509	0.00336	CcSEcCtD
Fluorescein—Oedema—Betamethasone—ankylosing spondylitis	0.000509	0.00336	CcSEcCtD
Fluorescein—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000509	0.00336	CcSEcCtD
Fluorescein—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000504	0.00333	CcSEcCtD
Fluorescein—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000504	0.00332	CcSEcCtD
Fluorescein—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000503	0.00332	CcSEcCtD
Fluorescein—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000502	0.00332	CcSEcCtD
Fluorescein—Shock—Dexamethasone—ankylosing spondylitis	0.000501	0.0033	CcSEcCtD
Fluorescein—Shock—Betamethasone—ankylosing spondylitis	0.000501	0.0033	CcSEcCtD
Fluorescein—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.0005	0.0033	CcSEcCtD
Fluorescein—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000499	0.00329	CcSEcCtD
Fluorescein—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000499	0.00329	CcSEcCtD
Fluorescein—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000497	0.00328	CcSEcCtD
Fluorescein—Tachycardia—Betamethasone—ankylosing spondylitis	0.000497	0.00328	CcSEcCtD
Fluorescein—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000492	0.00325	CcSEcCtD
Fluorescein—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000492	0.00325	CcSEcCtD
Fluorescein—Malaise—Prednisone—ankylosing spondylitis	0.00049	0.00323	CcSEcCtD
Fluorescein—Syncope—Prednisone—ankylosing spondylitis	0.000487	0.00321	CcSEcCtD
Fluorescein—Urticaria—Prednisolone—ankylosing spondylitis	0.000484	0.0032	CcSEcCtD
Fluorescein—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000484	0.00319	CcSEcCtD
Fluorescein—Pain—Triamcinolone—ankylosing spondylitis	0.00048	0.00317	CcSEcCtD
Fluorescein—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000477	0.00315	CcSEcCtD
Fluorescein—Hypotension—Dexamethasone—ankylosing spondylitis	0.000475	0.00314	CcSEcCtD
Fluorescein—Hypotension—Betamethasone—ankylosing spondylitis	0.000475	0.00314	CcSEcCtD
Fluorescein—Angiopathy—Methotrexate—ankylosing spondylitis	0.000473	0.00312	CcSEcCtD
Fluorescein—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000471	0.00311	CcSEcCtD
Fluorescein—Convulsion—Prednisone—ankylosing spondylitis	0.00047	0.00311	CcSEcCtD
Fluorescein—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00047	0.0031	CcSEcCtD
Fluorescein—Hypertension—Prednisone—ankylosing spondylitis	0.000469	0.00309	CcSEcCtD
Fluorescein—Chills—Methotrexate—ankylosing spondylitis	0.000468	0.00309	CcSEcCtD
Fluorescein—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000462	0.00305	CcSEcCtD
Fluorescein—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000461	0.00304	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000459	0.00303	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000458	0.00302	CcSEcCtD
Fluorescein—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000457	0.00302	CcSEcCtD
Fluorescein—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000457	0.00302	CcSEcCtD
Fluorescein—Discomfort—Prednisone—ankylosing spondylitis	0.000457	0.00301	CcSEcCtD
Fluorescein—Erythema—Methotrexate—ankylosing spondylitis	0.000454	0.003	CcSEcCtD
Fluorescein—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000449	0.00297	CcSEcCtD
Fluorescein—Urticaria—Triamcinolone—ankylosing spondylitis	0.000446	0.00294	CcSEcCtD
Fluorescein—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000445	0.00293	CcSEcCtD
Fluorescein—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000444	0.00293	CcSEcCtD
Fluorescein—Oedema—Prednisone—ankylosing spondylitis	0.000443	0.00292	CcSEcCtD
Fluorescein—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000443	0.00292	CcSEcCtD
Fluorescein—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000442	0.00292	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000439	0.0029	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000439	0.0029	CcSEcCtD
Fluorescein—Shock—Prednisone—ankylosing spondylitis	0.000436	0.00288	CcSEcCtD
Fluorescein—Pain—Betamethasone—ankylosing spondylitis	0.000435	0.00287	CcSEcCtD
Fluorescein—Pain—Dexamethasone—ankylosing spondylitis	0.000435	0.00287	CcSEcCtD
Fluorescein—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000435	0.00287	CcSEcCtD
Fluorescein—Tachycardia—Prednisone—ankylosing spondylitis	0.000432	0.00285	CcSEcCtD
Fluorescein—Skin disorder—Prednisone—ankylosing spondylitis	0.00043	0.00284	CcSEcCtD
Fluorescein—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000428	0.00283	CcSEcCtD
Fluorescein—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000421	0.00278	CcSEcCtD
Fluorescein—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000419	0.00277	CcSEcCtD
Fluorescein—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000419	0.00277	CcSEcCtD
Fluorescein—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000416	0.00275	CcSEcCtD
Fluorescein—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000416	0.00275	CcSEcCtD
Fluorescein—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000413	0.00273	CcSEcCtD
Fluorescein—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000412	0.00272	CcSEcCtD
Fluorescein—Malaise—Methotrexate—ankylosing spondylitis	0.000409	0.0027	CcSEcCtD
Fluorescein—Urticaria—Dexamethasone—ankylosing spondylitis	0.000404	0.00267	CcSEcCtD
Fluorescein—Urticaria—Betamethasone—ankylosing spondylitis	0.000404	0.00267	CcSEcCtD
Fluorescein—Dizziness—Prednisolone—ankylosing spondylitis	0.000403	0.00266	CcSEcCtD
Fluorescein—Asthenia—Triamcinolone—ankylosing spondylitis	0.000402	0.00266	CcSEcCtD
Fluorescein—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000402	0.00266	CcSEcCtD
Fluorescein—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000402	0.00266	CcSEcCtD
Fluorescein—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000401	0.00265	CcSEcCtD
Fluorescein—Paraesthesia—Prednisone—ankylosing spondylitis	0.000398	0.00263	CcSEcCtD
Fluorescein—Pruritus—Triamcinolone—ankylosing spondylitis	0.000397	0.00262	CcSEcCtD
Fluorescein—Cough—Methotrexate—ankylosing spondylitis	0.000396	0.00261	CcSEcCtD
Fluorescein—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000396	0.00261	CcSEcCtD
Fluorescein—Convulsion—Methotrexate—ankylosing spondylitis	0.000393	0.0026	CcSEcCtD
Fluorescein—Chest pain—Methotrexate—ankylosing spondylitis	0.000386	0.00255	CcSEcCtD
Fluorescein—Rash—Prednisolone—ankylosing spondylitis	0.000384	0.00254	CcSEcCtD
Fluorescein—Dermatitis—Prednisolone—ankylosing spondylitis	0.000384	0.00254	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000384	0.00253	CcSEcCtD
Fluorescein—Headache—Prednisolone—ankylosing spondylitis	0.000382	0.00252	CcSEcCtD
Fluorescein—Discomfort—Methotrexate—ankylosing spondylitis	0.000382	0.00252	CcSEcCtD
Fluorescein—Dizziness—Triamcinolone—ankylosing spondylitis	0.000371	0.00245	CcSEcCtD
Fluorescein—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00037	0.00244	CcSEcCtD
Fluorescein—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00037	0.00244	CcSEcCtD
Fluorescein—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000365	0.00241	CcSEcCtD
Fluorescein—Asthenia—Betamethasone—ankylosing spondylitis	0.000365	0.00241	CcSEcCtD
Fluorescein—Asthenia—Dexamethasone—ankylosing spondylitis	0.000365	0.00241	CcSEcCtD
Fluorescein—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000363	0.0024	CcSEcCtD
Fluorescein—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000362	0.00239	CcSEcCtD
Fluorescein—Nausea—Prednisolone—ankylosing spondylitis	0.000362	0.00239	CcSEcCtD
Fluorescein—Pruritus—Betamethasone—ankylosing spondylitis	0.00036	0.00238	CcSEcCtD
Fluorescein—Pruritus—Dexamethasone—ankylosing spondylitis	0.00036	0.00238	CcSEcCtD
Fluorescein—Skin disorder—Methotrexate—ankylosing spondylitis	0.00036	0.00237	CcSEcCtD
Fluorescein—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000358	0.00236	CcSEcCtD
Fluorescein—Vomiting—Triamcinolone—ankylosing spondylitis	0.000357	0.00235	CcSEcCtD
Fluorescein—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000356	0.00235	CcSEcCtD
Fluorescein—Rash—Triamcinolone—ankylosing spondylitis	0.000354	0.00233	CcSEcCtD
Fluorescein—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000353	0.00233	CcSEcCtD
Fluorescein—Rash—Methylprednisolone—ankylosing spondylitis	0.000353	0.00233	CcSEcCtD
Fluorescein—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000352	0.00233	CcSEcCtD
Fluorescein—Urticaria—Prednisone—ankylosing spondylitis	0.000352	0.00232	CcSEcCtD
Fluorescein—Headache—Triamcinolone—ankylosing spondylitis	0.000351	0.00232	CcSEcCtD
Fluorescein—Headache—Methylprednisolone—ankylosing spondylitis	0.000351	0.00231	CcSEcCtD
Fluorescein—Abdominal pain—Prednisone—ankylosing spondylitis	0.00035	0.00231	CcSEcCtD
Fluorescein—Hypotension—Methotrexate—ankylosing spondylitis	0.000346	0.00228	CcSEcCtD
Fluorescein—Dizziness—Betamethasone—ankylosing spondylitis	0.000336	0.00222	CcSEcCtD
Fluorescein—Dizziness—Dexamethasone—ankylosing spondylitis	0.000336	0.00222	CcSEcCtD
Fluorescein—Nausea—Triamcinolone—ankylosing spondylitis	0.000333	0.0022	CcSEcCtD
Fluorescein—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000333	0.0022	CcSEcCtD
Fluorescein—Nausea—Methylprednisolone—ankylosing spondylitis	0.000332	0.00219	CcSEcCtD
Fluorescein—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00033	0.00218	CcSEcCtD
Fluorescein—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000326	0.00216	CcSEcCtD
Fluorescein—Vomiting—Dexamethasone—ankylosing spondylitis	0.000324	0.00214	CcSEcCtD
Fluorescein—Vomiting—Betamethasone—ankylosing spondylitis	0.000324	0.00214	CcSEcCtD
Fluorescein—Rash—Dexamethasone—ankylosing spondylitis	0.000321	0.00212	CcSEcCtD
Fluorescein—Rash—Betamethasone—ankylosing spondylitis	0.000321	0.00212	CcSEcCtD
Fluorescein—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000321	0.00212	CcSEcCtD
Fluorescein—Dermatitis—Betamethasone—ankylosing spondylitis	0.000321	0.00212	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00032	0.00211	CcSEcCtD
Fluorescein—Headache—Betamethasone—ankylosing spondylitis	0.000319	0.0021	CcSEcCtD
Fluorescein—Headache—Dexamethasone—ankylosing spondylitis	0.000319	0.0021	CcSEcCtD
Fluorescein—Asthenia—Prednisone—ankylosing spondylitis	0.000318	0.0021	CcSEcCtD
Fluorescein—Pain—Methotrexate—ankylosing spondylitis	0.000317	0.00209	CcSEcCtD
Fluorescein—Pruritus—Prednisone—ankylosing spondylitis	0.000314	0.00207	CcSEcCtD
Fluorescein—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000305	0.00201	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000303	0.002	CcSEcCtD
Fluorescein—Nausea—Dexamethasone—ankylosing spondylitis	0.000302	0.002	CcSEcCtD
Fluorescein—Nausea—Betamethasone—ankylosing spondylitis	0.000302	0.002	CcSEcCtD
Fluorescein—Urticaria—Methotrexate—ankylosing spondylitis	0.000294	0.00194	CcSEcCtD
Fluorescein—Dizziness—Prednisone—ankylosing spondylitis	0.000293	0.00193	CcSEcCtD
Fluorescein—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000293	0.00193	CcSEcCtD
Fluorescein—Vomiting—Prednisone—ankylosing spondylitis	0.000282	0.00186	CcSEcCtD
Fluorescein—Rash—Prednisone—ankylosing spondylitis	0.000279	0.00184	CcSEcCtD
Fluorescein—Dermatitis—Prednisone—ankylosing spondylitis	0.000279	0.00184	CcSEcCtD
Fluorescein—Headache—Prednisone—ankylosing spondylitis	0.000278	0.00183	CcSEcCtD
Fluorescein—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000273	0.0018	CcSEcCtD
Fluorescein—Asthenia—Methotrexate—ankylosing spondylitis	0.000266	0.00175	CcSEcCtD
Fluorescein—Nausea—Prednisone—ankylosing spondylitis	0.000263	0.00174	CcSEcCtD
Fluorescein—Pruritus—Methotrexate—ankylosing spondylitis	0.000262	0.00173	CcSEcCtD
Fluorescein—Dizziness—Methotrexate—ankylosing spondylitis	0.000245	0.00162	CcSEcCtD
Fluorescein—Vomiting—Methotrexate—ankylosing spondylitis	0.000235	0.00155	CcSEcCtD
Fluorescein—Rash—Methotrexate—ankylosing spondylitis	0.000234	0.00154	CcSEcCtD
Fluorescein—Dermatitis—Methotrexate—ankylosing spondylitis	0.000233	0.00154	CcSEcCtD
Fluorescein—Headache—Methotrexate—ankylosing spondylitis	0.000232	0.00153	CcSEcCtD
Fluorescein—Nausea—Methotrexate—ankylosing spondylitis	0.00022	0.00145	CcSEcCtD
